Eledon Pharmaceuticals, Inc. (ELDN) Earnings
|
Expand Research on ELDN
| Next EPS Date | 11/18/26 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -13.6% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +1.0% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/18/26  |
Q326 | N/A | -$0.19 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/13/26 | Q226 | -$0.27 | -$0.15 | -$0.12 | N/A | N/A | N/A |  | | Details | |
| 8/12/26 |
Q226 | N/A | -$0.15 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/6/26 |
Q226 | N/A | -$0.15 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/13/26 |
Q126 | -$0.33 | -$0.18 | -$0.15 | N/A | N/A | N/A | | | Details | |
| 5/7/26 |
Q126 | N/A | -$0.18 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/19/26 |
Q425 | N/A | -$0.21 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/13/25 |
Q325 | N/A | -$0.24 | N/A | N/A | N/A | N/A | N/A | N/A |
